While the National Opioid Settlement appears at surface-level to be $45 billion dollars healthcare professionals obviously need to read between the lines – every single one of them. This presentation will delve into the National Opioid Settlement financials, controlled substance programs, and specifically, granular “red flags” stated within. No one ever enjoys answers to difficult patient care scenarios being cookie-cutter “differs patient to patient” responses, yet isn’t that the reality of balancing standardized “red flags” while adhering to the federal regulations “corresponding responsibility” and accounting for reasonable patient variations? Join in for a dynamic discussion on the National Opioid Settlement and what it means for every single pharmacy on this planet.